Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 10999 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zegkos, T., Parcharidou D., Ntelios D., Efthimiadis G., & Karvounis H. (2018).  The Prognostic Implications of Two-Dimensional Speckle Tracking Echocardiography in Hypertrophic Cardiomyopathy: Current and Future Perspectives.. Cardiol Rev. 26(3), 130-136.
Zecevic, N., Arsenijevic V., Manolakos E., Papoulidis I., Theocharis G., Sartsidis A., et al. (2020).  New Compound Heterozygous Splice Site Mutations of the Skeletal Muscle Ryanodine Receptor () Gene Manifest Fetal Akinesia: A Linkage with Congenital Myopathies.. Mol Syndromol. 11(2), 104-109.
Zavos, C., Kountouras J., Deretzi G., Tsona A., Polyzos S. A., Mantzoukis K., et al. (2012).  Hpn protein as a mediator between Helicobacter pylori infection and Alzheimer's disease in sub-populations worldwide.. Med Hypotheses. 78(2), 349-50.
Zavos, C., Kountouras J., Katsinelos P., Polyzos S. A., Deretzi G., Zavos N., et al. (2011).  Association between Helicobacter pylori infection and fibromyalgia syndrome.. Clin Rheumatol. 30(2), 301-2.
Zavos, A., Daponte A., Garas A., Verykouki C., Papanikolaou E., Anifandis G., et al. (2013).  Double versus single homologous intrauterine insemination for male factor infertility: a systematic review and meta-analysis.. Asian J Androl. 15(4), 533-8.
Zavos, C., Kountouras J., Katsinelos P., Polyzos S. A., Deretzi G., Zavos N., et al. (2011).  Modern industrialization may increase primary open-angle glaucoma prevalence through easier transmission of Helicobacter pylori infection.. Med Hypotheses. 76(5), 766-7.
Zavos, C., Kountouras J., Katsinelos P., Polyzos S. A., Deretzi G., Zavos N., et al. (2011).  Low aqueous humor ghrelin levels in open-angle glaucoma patients may correlate with Helicobacter pylori-associated apoptotic mechanisms.. Hippokratia. 15(3), 287-8.
Zarpalas, D., Gkontra P., Daras P., & Maglaveras N. (2014).  Gradient-based reliability maps for ACM-based segmentation of hippocampus.. IEEE Trans Biomed Eng. 61(4), 1015-26.
Zarogoulidou, V., Panagopoulou E., Papakosta D., Petridis D., Porpodis K., Zarogoulidis K., et al. (2015).  Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department.. J Thorac Dis. 7(Suppl 1), S12-9.
Zarogoulidis, P., Kioumis I., Lampaki S., Organtzis J., Porpodis K., Spyratos D., et al. (2014).  Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.. Drug Des Devel Ther. 8, 1065-72.
Zarogoulidis, P., Petanidis S., Kioseoglou E., Domvri K., Anestakis D., & Zarogoulidis K. (2015).  MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.. Cell Signal. 27(8), 1576-88.
Zarogoulidis, K., Papaiwannou A., Lazaridis G., Karavergou A., Lampaki S., Baka S., et al. (2015).  Pneumothorax from diagnosis to treatment, hands on course: Part II.. Ann Transl Med. 3(3), 41.
Zarogoulidis, P., Pataka A., Terzi E., Hohenforst-Schmidt W., Machairiotis N., Huang H., et al. (2013).  Intensive care unit and lung cancer: when should we intubate?. J Thorac Dis. 5 Suppl 4, S407-12.
Zarogoulidis, P., Papanas N., Kouliatsis G., Spyratos D., Zarogoulidis K., & Maltezos E. (2011).  Inhaled insulin: too soon to be forgotten?. J Aerosol Med Pulm Drug Deliv. 24(5), 213-23.
Zarogoulidis, P., Papanas N., Kioumis I., Chatzaki E., Maltezos E., & Zarogoulidis K. (2012).  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.. Eur J Clin Pharmacol. 68(5), 479-503.
Zarogoulidis, P., Huang H., Yang M., Zhou J., Jiao Y., Wang Q., et al. (2020).  Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?. J Cancer. 11(6), 1606-1613.
Zarogoulidis, P., Chinelis P., Efthymiou C., Athanasiadou A., Mpikos V., Papatsibas G., et al. (2017).  EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50.. Respir Med Case Rep. 22, 7-10.
Zarogoulidis, K., Mylonaki E., Kakavelas P., Zarogoulidis P., Tsiouda T., Rapti E., et al. (2009).  Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer.. Lung Cancer. 66(2), 226-30.
Zarogoulidis, P., Tsakiridis K., Kioumis I., & Zarogoulidis K. (2014).  Cardiothoracic diseases: basic treatment.. J Thorac Dis. 6 Suppl 1, S1.
Zarogoulidis, P., Glaros D., Kontakiotis T., Froudarakis M., Kioumis I., Kouroumichakis I., et al. (2012).  Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections.. Int J Gen Med. 5, 175-82.
Zarogoulidis, P., Tryfon S., Sapalidis K., Tsakiridis K., Baka S., Huang H., et al. (2020).  Bronchial HPV; the good the bad and the unknown.. Respir Med Case Rep. 30, 101053.
Zarogoulidis, P., Tsakiridis K., & Zarogoulidis K. (2013).  Lung cancer: an update on current and future diagnostic and treatment techniques.. J Thorac Dis. 5 Suppl 4, S341.
Zarogoulidis, P., Hohenforst-Schmidt W., Huang H., Sahpatzidou D., Freitag L., Sakkas L., et al. (2014).  A gene therapy induced emphysema model and the protective role of stem cells.. Diagn Pathol. 9, 195.
Zarogoulidis, P., Darwiche K., Yarmus L., Spyratos D., Secen N., Hohenforst-Schmidt W., et al. (2014).  Defense mechanisms of the respiratory system and aerosol production systems.. Med Chem. 10(2), 123-36.
Zarogoulidis, P., Huang H., Bai C., Kosmidis C., Porpodis K., Kallianos A., et al. (2018).  A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking.. Respir Med Case Rep. 23, 38-42.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές